Company: RGNT
Filing Date: 2025-07-07
Form Type: F-1/A
Source: 0001213900-25-061821
Chunk: 170

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-07-07
Form: F-1/A
Chunk 170
---
 complaints as to the management of our business and the protection to be provided to such employees. |

Compensation Committee and Compensation Policy

We have established a compensation
committee to be effective as of the effective time of the registration statement to which this prospectus relates. The members of this
committee will be Mr. Keith Valentine, Mr. Pini Ben-Elazar, and Mr. Cohen-Arazi. Mr. Cohen-Arazi will serve as the chairperson of the
committee.

<div align='center'>100</div>

Israeli Companies Law Requirements

Under the Companies Law,
the board of directors of a public company must appoint a compensation committee. The duties of the compensation committee include the
recommendation to our board of directors of a policy regarding the terms of engagement of office holders (as defined in the Companies
Law), to which we refer as a compensation policy. The term “office holder” is defined under the Companies Law as a chief
executive officer (referred to in the Companies Law as the general manager), chief business manager, deputy general manager, vice general
manager, any other person assuming the responsibilities of any of these positions regardless of that person’s title, a director
and any other manager directly subordinate to the general manager. That policy must be adopted by our board of directors, after considering
the recommendations of the compensation committee, and will need to be approved by our shareholders, which approval requires what we
refer to as a Special Majority Approval for Compensation. A Special Majority Approval for Compensation requires shareholder approval
by a majority vote of the Ordinary Shares present and voting at a meeting of shareholders called for such purpose, provided that either:
(i) such majority includes at least a majority of the Ordinary shares held by all shareholders who are not controlling shareholders and
do not have a personal interest in such compensation arrangement, excluding abstentions; or (ii) the total number of Ordinary shares
of non-controlling shareholders and shareholders who do not have a personal interest in the compensation arrangement and who vote against
the arrangement does not exceed 2% of the company’s aggregate voting rights.

Even if our shareholders
do not approve the compensation policy, the board of directors may resolve to approve the compensation policy if and to the extent the
compensation committee and the board determine, in its judgment following internal discussions and after reconsidering the compensation
policy, that approval of the compensation policy is in the best interests of the Company.

Pursuant to regulations promulgated
under the Companies Law, if a company adopts a